Seven immune checkpoint inhibitors, targeting the PD-1, PD-L1, or CTLA-4 proteins, are currently approved for the treatment of cancer....
The new year brings a new chapter in the holy book of cancer biology with the publication in the...
Each year in the United States, about 14,480 women are diagnosed with cervical cancer, and about 4,290 women die of...
The recently launched Cancer Research Communications (CRC) is the latest addition to the AACR’s journal portfolio. The new journal...
Surrounding a tumor is a vast network of blood vessels, immune cells, proteins, and even bacteria, all of which...
The year 2021 defied our expectations in a variety of ways. The delta and omicron COVID-19 variants imposed unprecedented...
On December 23, 1971, when President Richard Nixon signed the National Cancer Act of 1971 into law, cancer was considered a death sentence. Only 42 percent of those diagnosed with cancer survived five years past diagnosis,...
When the COVID-19 pandemic forced much of the world to shut down, and many days seemed bleak, it was...
Triple-negative breast cancer (TNBC) is aggressive, with high risk of metastasis and recurrence, and is challenging to treat due to a lack of effective targeted therapies. However, a higher...
When Abigail Johnston’s first child entered preschool six years ago, a vigilant pediatrician recommended an unusual strategy for minimizing...